Filter
7501
Filtered Results: 7501
Text search:
protective
factors
Featured
Recommendations
680
New Publications
1936
Language
Document type
No document type
4261
Studies & Reports
1335
Guidelines
938
Manuals
389
Strategic & Response Plan
248
Fact sheets
135
Training Material
110
Situation Updates
45
Brochures
12
Resource Platforms
12
Infographics
12
Online Courses
3
App
1
Countries / Regions
Global
321
India
312
Kenya
200
Ethiopia
159
Uganda
154
Sierra Leone
149
Western and Central Europe
146
South Africa
136
Liberia
130
Nigeria
127
Nepal
124
Myanmar / Burma
117
Zambia
108
Africa
108
Latin America and the Carribbean
103
Syria
100
Rwanda
98
Malawi
94
Tanzania
92
Bangladesh
88
Ukraine
79
Ghana
78
Congo, Democratic Republic of
67
Philippines
65
Indonesia
56
Namibia
55
Eastern Europe
54
Zimbabwe
52
South–East Asia Region
52
South Sudan
51
Lesotho
46
Cambodia
43
West and Central Africa
43
Russia
42
Guinea
41
Senegal
39
East and Southern Africa
39
Asia
38
Germany
37
Mozambique
37
Brazil
36
Yemen
35
Middle East and North Africa
29
Cameroon
28
Botswana
28
Haiti
27
Pakistan
27
Afghanistan
27
Colombia
27
Venezuela
27
Burkina Faso
25
Eswatini/ Swaziland
24
Eastern Europe and Central Asia
23
Lebanon
21
Central African Republic
21
Western Pacific Region
18
Somalia
17
Thailand
17
Sudan
17
Iraq
16
Jordan
16
Vietnam
16
USA
15
Benin
15
Mali
12
Paraguay
12
Laos
12
Peru
11
Albania
11
Tajikistan
11
China
10
Sri Lanka
10
Chile
10
Côte d’Ivoire / Ivory Coast
9
Angola
9
Palestine
9
Niger
8
Turkey
8
Argentina
8
Madagascar
8
Moldova
8
Georgia
8
Burundi
7
Mexico
7
Iran
7
Guinea-Bissau
6
Egypt
6
Papua New Guinea
6
North Macedonia
6
Ecuador
6
Kyrgyzstan
6
Spain
6
Chad
5
Libya
5
Kazakhstan
5
North America
5
United Kingdom
5
Portugal
5
Togo
4
Southern Africa
4
Canada
4
Timor Leste/ East Timor
4
Turkmenistan
4
Jamaica
4
Tunisia
4
Morocco
3
Saudi Arabia
3
Gambia
3
Bolivia
3
Greece
3
Armenia
3
Bosnia and Herzegovina
3
Serbia
2
Croatia
2
Poland
2
Italy
2
Djibouti
2
Qatar
2
Romania
2
Lithuania
2
Uzbekistan
2
Gabon
2
Japan
2
France
2
Belarus
2
Malaysia
1
Ireland
1
Singapore
1
Vanuatu
1
Dominican Republic
1
Switzerland
1
Hungary
1
Honduras
1
El Salvador
1
Guatemala
1
Other region
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Congo-Brazzaville
1
Bulgaria
1
Estonia
1
Australia
1
Denmark
1
Belgium
1
Mauritius
1
Norway
1
Algeria
1
Azerbaijan
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2643
Clinical Guidelines
503
Public Health
459
Women & Child Health
393
Key Resources
379
Capacity Building
146
Pharmacy & Technologies
65
Annual Report MEDBOX
1
Toolboxes
COVID-19
731
Mental Health
664
HIV
546
TB
343
Disability
333
Planetary Health
314
Conflict
231
Rapid Response
209
Ebola
205
Caregiver
195
Refugee
186
NCDs
153
AMR
148
Global Health Education
140
NTDs
138
Natural Hazards
118
Pharmacy
110
Specific Hazards
60
Health Financing Toolbox
59
Cholera
41
Polio
39
Zika
38
Social Ethics
21
Typhoon
5
South Sudan
2
Health Financing
1
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation and certification across PMJAY empanelled hospitals from three diffe...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Loss and damage is an urgent concern, driven by the increasingly harmful effects of climate change. Communities are experiencing new types and forms of climate impact, of higher frequency and intensity, which they are not equipped to handle. These impacts compel vulnerable communities to migrate to ...
This draft Roadmap for the Global Health for Peace Initiative has been developed in response to decision WHA75(24) of the 75th World Health Assembly (2022), which requested that WHO develop, in full consultation with Member States and Observers, and in full collaboration with other organizations of ...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra...
A key component of elimination is to reduce the number
of unmanaged trachomatous trichiasis cases to less than
1 per 1,000 population in affected areas. This will require
not only a large increase in the number of surgeries
performed, but also improvements in the quality of surgery
and in the e...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Revised and expanded version of the Guidelines
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
States have committed and assumed obligations to address multiple and intersecting forms of discrimination against refugees, internally displaced persons, asylum seekers, returnees and stateless persons. The Global Compact on Refugees places ending discrimination of any kind based on the grounds of ...
Breast cancer is the most common cancer worldwide and the leading cause of cancer deaths among women, disproportionately affecting low- and middle-income countries. The Global Breast Cancer Initiative strives to reduce breast cancer mortality by 2.5 percent per year, which over a 20-year period can ...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
